Carregant...
Immunomodulatory Drugs in the Management of SARS-CoV-2
With the onset of the global pandemic in 2020 of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), there has been increasing research activity around certain disease-modifying drugs that are used for the management of inflammatory disorders such as rheumatoid arthritis, spondyloarthrosis...
Guardat en:
Autors principals: | , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Frontiers Media S.A.
2020-08-01
|
Col·lecció: | Frontiers in Immunology |
Matèries: | |
Accés en línia: | https://www.frontiersin.org/article/10.3389/fimmu.2020.01844/full |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|